Home » Erectile Dysfunction Treatment Drugs Market

Erectile Dysfunction Treatment Drugs Market By Drug Type (Phosphodiesterase Type 5 Inhibitors (Pde5 Inhibitors), Prostaglandin E1) – Growth, Future Prospects And Competitive Analysis, 2017 – 2025

Price: $4999

Published: | Report ID: 5531 | Report Format : PDF

Market Insights

Erectile dysfunction is a very common sexual problem, affecting 100 million people worldwide. It is often contributed by neurological disorders, cardiovascular diseases, diabetes, hormonal imbalance, and obesity. Erectile dysfunction is also age-related, as well as associated with certain risk factors such as tobacco and alcohol use, certain medications and medical treatment, injuries, and psychological conditions.

The rising prevalence of chronic diseases, particularly diabetes and cardiovascular disease, as well as sedentary lifestyles, are expected to fuel the growth of the erectile dysfunction treatment drug market. Market penetration by local players manufacturing generic drugs also contributes to the growth of the erectile dysfunction treatment drug market. However, the erectile dysfunction treatment drug market is expected to decline due to the patent expiration of commercially available branded drugs. Social stigma about sexual issues among the public in developing countries poses a challenge to the overall growth of the market. The growing trend of alternative therapies like natural medicine, surgery, and other medical devices might hinder the growth of the erectile dysfunction treatment drug market. Pipeline drugs under clinical trials are projected to emerge as a growth opportunity in the erectile dysfunction treatment drug market in future years.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample
CTA Design Element 3

The scope of this research study entitled “Erectile Dysfunction Treatment Drugs Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025” is to provide company executives, developers, investors, and industry participants with actionable information with in-depth analysis to take tactical decisions and strategic initiatives associated with the projections in the global erectile dysfunction treatment drug market. The research report presents major developments and trends in the global erectile dysfunction treatment drugs market, as well as market size and forecast. Global health concerns, increasing research initiatives to develop new products, rising demand among consumers, and an impressive pipeline product portfolio strongly boost the growth of the erectile dysfunction treatment drugs market.

This report contains an overview of the global erectile dysfunction treatment drug market in terms of drug type and geographical distribution. The erectile dysfunction treatment drug market is divided into Phosphodiesterase type 5 inhibitors (PDE5 inhibitors), Prostaglandin E1, and others based on drug type. This report presents the market size and forecasts for each section for the period 2015-2025, as well as CAGRs for the forecast period 2017-2025.

Geographically, the erectile dysfunction treatment drug market is presented as five major regions, which are further segmented as follows:

  • North America
    • The United States
    • Canada
  • Europe
    • The United Kingdom
    • Germany
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia Pacific
  • Latin America Middle East, and Africa
    • Brazil
    • Mexico
    • rest of Latin America
  • Middle East and Africa
    • Gulf Cooperation Council
    • Rest of the Middle East and Africa

This report is comprised of data in order to determine market size, with forecasts for each geographical region for the years 2015–2025, along with CAGRs for the forecast duration of 2017–2025. To gain a better understanding, additional cross-sectional studies are presented in terms of drug type and constituent country/region level markets.

This research report incorporates qualitative assessment components such as market dynamics to achieve an understanding of the current and future global market trends of the erectile dysfunction treatment drug market. A detailed description of competitive assessment tools such as partnerships and collaborations, major agreements, competitive landscape analysis, and market attractiveness assessment by key players is mentioned in this report. Moreover, this research report includes a profile of major players in the erectile dysfunction treatment drug market. The major players profiled in this report are Pfizer Inc., Dong-A Pharmaceutical Co. Ltd., Vivus, Inc., Meda Pharmaceuticals, Bayer AG, Johnson & Johnson Services, Apricus Biosciences, and Eli Lilly and Company.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Based on the different types of drugs used to treat erectile dysfunction, the erectile dysfunction treatment drug market is categorized on the following basis:

Phosphodiesterase type 5 inhibitors (PDE5 inhibitors)

  • Sildenafil (Viagra)
  • Tadalafil (Adcirca, Cialis)
  • Vardenafil (Levitra, Staxyn)
  • Avanafil (Stendra)
  • Prostaglandin E1
  • Alprostadil (Caverject, Edex, Muse, Prostin VR Pediatric)
  • Others

The phosphodiesterase type 5 inhibitors segment is estimated to be the leading one in terms of revenue and better treatment outcomes in the erectile dysfunction treatment drugs market. PDE5 inhibitors are mostly preferred owing to their easy administration, affordable cost, and lowest risk caused by this class of drugs. Sildenafil, tadalafil, and vardenafil act by relaxing blood vessels and improving blood circulation, followed by sexual stimulation. Sildenafil is the most common and well-known medication, which has been used for a very long time for its effective treatment of impotence. Minimal adverse effects, a lower cost, and simple administration of sildenafil drugs make this drug the most preferable among physicians, which supports the growth of the erectile dysfunction treatment drug market. The increasing popularity of tadalafil drugs due to their longer duration of action and improved erection rate also drives the global erectile dysfunction market. Avanafil, on the other hand, is less popular than other PDE5 inhibitor drugs due to its higher cost and side effects. Alprostadil drugs (prostaglandin E1 vasodilator) are used in either injectable form or as suppositories, the former being less effective from a treatment perspective.

Geography-wise, the global erectile dysfunction treatment drug market is cumulative across North America, Europe, Asia Pacific, the Middle East, Africa, and Latin America.

North America is anticipated to dominate the erectile dysfunction treatment drug market, followed by Europe. According to the Massachusetts Male Aging Study, the prevalence of erectile dysfunction is around 52%, which means that 30 million men in the United States have been suffering from various degrees of erectile impairment. Erectile dysfunction is more common in people over the age of 40; the aging population and changing public perception have driven the market for erectile dysfunction treatment drugs. North America is expected to hold the maximum market share due to the presence of key erectile dysfunction treatment drug manufacturers, growing demand for drugs, expanding production of generic drugs, and increasing R&D expenditure for product development. Erectile dysfunction affects more than 20 million people in Europe. The existence of such a huge population affected by erectile dysfunction, the constantly rising prevalence of chronic diseases, and competition among generic drug manufacturers for market share act as key driving factors for market growth in the European region.

Asia Pacific is predicted to witness the fastest growth in future years on account of developing healthcare infrastructures, emerging personal income, and gradual growth in health awareness among the public, whereas the Middle East and Africa are expected to exhibit steady and constant market growth.

The detailed regional classification of the global erectile dysfunction treatment drug market is as follows:

  • North America (Canada and the United States)
  • Europe (the United Kingdom, Germany, and the rest of the European countries)
  • Asia Pacific (China, India, Japan, and the rest of Asia-Pacific countries)
  • Latin America (Brazil, Mexico, and the other LATAM nations)
  • Middle East and Africa (GCC, South Africa, and the rest of the MEA)

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Erectile Dysfunction Treatment Drugs Market Portraiture
2.1.1. Global Erectile Dysfunction Treatment Drugs Market, by Drug Type, 2016 (US$ Mn)
2.1.2. Global Erectile Dysfunction Treatment Drugs Market, by Geography, 2016 Vs. 2025 (Value %)

Chapter 3. Erectile Dysfunction Treatment Drugs: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Erectile Dysfunction: Epidemiology
3.3. Erectile Dysfunction Treatment Drugs: Future Trends
3.4. Drivers
3.5. Challenges
3.6. Opportunities
3.7. Attractive Investment Proposition, by Geography, 2016
3.8. Major Agreements, Partnerships and Collaborations
3.9. Competitive Landscape
3.9.1. Competitive Landscape, by Key Players, 2016

Chapter 4. Global Erectile Dysfunction Treatment Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
4.1. Overview
4.1.1. Attractive Investment Proposition: Global Erectile Dysfunction Treatment Drugs Market, by Drug Type
4.2. Phosphodiesterase Type 5 Inhibitors (PDE5 Inhibitors)
4.2.1. Sildenafil (Viagra)
4.2.2. Tadalafil (Adcirca, Cialis)
4.2.3. Vardenafil (Levitra, Staxyn)
4.2.4. Avanafil (Stendra)
4.3. Prostaglandin E1
4.3.1. Alprostadil (Caverject, Edex, Muse, Prostin VR Pediatric)
4.4. Others

Chapter 5. Global Erectile Dysfunction Treatment Drugs Market: Pipeline Analysis
5.1. Overview
5.2. Phase III (Market estimations by 2025)
5.2.1. HCP 1302 (Hanmi Pharmaceutical)
5.3. Phase II (Qualitative Information)
5.4. Phase I (Qualitative Information)

Chapter 6. Global Erectile Dysfunction Treatment Drugs Market, by Geography, 2015 – 2025 (US$ Mn)
6.1. Overview
6.2. North America Erectile Dysfunction Treatment Drugs Market Analysis, 2015 – 2025
6.2.1. North America Erectile Dysfunction Treatment Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
6.2.2. North America Erectile Dysfunction Treatment Drugs Market, by Country, 2015 – 2025 (US$ Mn)
6.2.2.1. U.S.
6.2.2.2. Canada
6.3. Europe Erectile Dysfunction Treatment Drugs Market Analysis, 2015 – 2025
6.3.1. Europe Erectile Dysfunction Treatment Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
6.3.2. Europe Erectile Dysfunction Treatment Drugs Market, by Country, 2015 – 2025 (US$ Mn)
6.3.2.1. U.K.
6.3.2.2. Germany
6.3.2.3. Rest of Europe
6.4. Asia Pacific Erectile Dysfunction Treatment Drugs Market Analysis, 2015 – 2025
6.4.1. Asia Pacific Erectile Dysfunction Treatment Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
6.4.2. Asia Pacific Erectile Dysfunction Treatment Drugs Market, by Country, 2015 – 2025 (US$ Mn)
6.4.2.1. Japan
6.4.2.2. China
6.4.2.3. India
6.4.2.4. Rest of APAC
6.5. Latin America Erectile Dysfunction Treatment Drugs Market Analysis, 2015 – 2025
6.5.1. Latin America Erectile Dysfunction Treatment Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
6.5.2. Latin America Erectile Dysfunction Treatment Drugs Market, by Country, 2015 – 2025 (US$ Mn)
6.5.2.1. Brazil
6.5.2.2. Mexico
6.5.2.3. Rest of Latin America
6.6. Middle East & Africa (MEA) Erectile Dysfunction Treatment Drugs Market Analysis, 2015 – 2025
6.6.1. MEA Erectile Dysfunction Treatment Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
6.6.2. MEA Erectile Dysfunction Treatment Drugs Market, by Region, 2015 – 2025 (US$ Mn)
6.6.2.1. GCC
6.6.2.2. South Africa
6.6.2.3. Rest of MEA

Chapter 7. Company Profiles
7.1. Apricus Biosciences
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Bayer AG
7.3. Dong-A Pharmaceutical Co. Ltd
7.4. Eli Lilly and Company
7.5. Johnson & Johnson Services
7.6. Meda Pharmaceuticals
7.7. Pfizer Inc.
7.8. Vivus, Inc.

List of Figures

FIG. 1 Erectile Dysfunction Treatment Drugs: Market Segmentation
FIG. 2 Global Erectile Dysfunction Treatment Drugs Market Share, by Drug Type, 2016 (US$ Mn)
FIG. 3 Global Erectile Dysfunction Treatment Drugs Market, by Geography, 2016 Vs. 2025 (Value %)
FIG. 4 Attractive Investment Proposition, by Geography, 2016
FIG. 5 Market Competition Landscape, by Key Players, 2016
FIG. 6 Global Phosphodiesterase Type 5 Inhibitors (PDE5 Inhibitors) Market in Erectile Dysfunction Treatment Drugs, 2015 – 2025 (US$ Mn)
FIG. 7 Global Sildenafil (Viagra) Market in Erectile Dysfunction Treatment Drugs, 2015 – 2025 (US$ Mn)
FIG. 8 Global Tadalafil (Adcirca, Cialis) Market in Erectile Dysfunction Treatment Drugs, 2015 – 2025 (US$ Mn)
FIG. 9 Global Vardenafil (Levitra, Staxyn) Market in Erectile Dysfunction Treatment Drugs, 2015 – 2025 (US$ Mn)
FIG. 10 Global Avanafil (Stendra) Market in Erectile Dysfunction Treatment Drugs, 2015 – 2025 (US$ Mn)
FIG. 11 Global Prostaglandin E1 Market in Erectile Dysfunction Treatment Drugs, 2015 – 2025 (US$ Mn)
FIG. 12 Global Alprostadil (Caverject, Edex, Muse, Prostin VR Pediatric) Market in Erectile Dysfunction
Treatment Drugs, 2015 – 2025 (US$ Mn)
FIG. 13 Global Others Erectile Dysfunction Treatment Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 14 U.S. Erectile Dysfunction Treatment Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 15 Canada Erectile Dysfunction Treatment Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 16 U.K. Erectile Dysfunction Treatment Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 17 Germany Erectile Dysfunction Treatment Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 18 Rest Of Europe Erectile Dysfunction Treatment Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 19 Japan Erectile Dysfunction Treatment Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 20 China Erectile Dysfunction Treatment Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 21 India Erectile Dysfunction Treatment Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 22 Rest Of Asia Pacific Erectile Dysfunction Treatment Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 23 Brazil Erectile Dysfunction Treatment Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 24 Mexico Erectile Dysfunction Treatment Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 25 Rest Of Latin America Erectile Dysfunction Treatment Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 26 GCC Erectile Dysfunction Treatment Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 27 South Africa Erectile Dysfunction Treatment Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 28 Rest Of Middle East And Africa Erectile Dysfunction Treatment Drugs Market, 2015 – 2025 (US$ Mn)

List of Tables

TABLE 1 Global Erectile Dysfunction Treatment Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 2 Global Erectile Dysfunction Treatment Drugs Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 3 North America Erectile Dysfunction Treatment Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 4 North America Erectile Dysfunction Treatment Drugs Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 5 Europe Erectile Dysfunction Treatment Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 6 Europe Erectile Dysfunction Treatment Drugs Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 7 Asia Pacific Erectile Dysfunction Treatment Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 8 Asia Pacific Erectile Dysfunction Treatment Drugs Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 9 Latin America Erectile Dysfunction Treatment Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 10 Latin America Erectile Dysfunction Treatment Drugs Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 11 Middle East And Africa Erectile Dysfunction Treatment Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 12 Middle East And Africa Erectile Dysfunction Treatment Drugs Market, by Region, 2015 – 2025 (US$ Mn)
TABLE 13 Apricus Biosciences: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 14 Bayer AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 15 Dong-A Pharmaceutical Co. Ltd: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 16 Eli Lilly and Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 17 Johnson & Johnson Services: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 18 Meda Pharmaceuticals: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 19 Pfizer Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 20 Vivus, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)

Frequently Asked Questions: 

What is the size of Erectile Dysfunction Treatment Drugs Market?

The market for Erectile Dysfunction Treatment Drugs is expected to reach US$ 6.6 Bn in 2025.

What is the Erectile Dysfunction Treatment Drugs Market CAGR?

The Erectile Dysfunction Treatment Drugs market is expected to see significant CAGR growth over the coming years,at XX%.

What is the Forecast period considered for Erectile Dysfunction Treatment Drugs Market?

The report is forecasted from 2017-2025.

What is the base year considered for Erectile Dysfunction Treatment Drugs Market?

The base year of this report is 2016.

Who are the major players in this Market?

Apricus Biosciences,Bayer AG,Dong-A Pharmaceutical Co. Ltd,Eli Lilly and Company,Johnson & Johnson Services are some of the major players in the global markHet.

Clostridioides Difficile (C. diff) Treatment Market

Published:
Report ID: 33667

Sphingosine-1-Receptor Modulators Drugs Market

Published:
Report ID: 33649

Neuromyelitis Optica Therapy Market

Published:
Report ID: 33583

Pediatric Bladder Treatment Market

Published:
Report ID: 33540

Neurotrophic Keratitis Treatment Market

Published:
Report ID: 33425

Precision Medicine Market

Published:
Report ID: 11123

Eosinophilic Pneumonia Treatment Market

Published:
Report ID: 5486

Myelodysplastic Syndrome Market

Published:
Report ID: 32821

US Retail Pharmacy Market

Published:
Report ID: 32801

Basal Cell Carcinoma (BCC) Treatment Market

Published:
Report ID: 32698

Paroxysmal Nocturnal Hemoglobinuria Market

Published:
Report ID: 8654

Reversible Airway Diseases Treatment Market

Published:
Report ID: 32531

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN